Search research articles
Contact Us
Filters
Showing results (111-120 of 142) with videos related to
Page
of 15
Sort By:
Urologic Oncology
|
April 4, 2020
Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer
Hongyang Qian, Xiaoguang Shao, Yinjie Zhu, et al.
Plos One
|
September 9, 2025
Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators
Riken Chen, Dingyu Guo, Jiahua Pan, et al.
Small Methods
|
January 23, 2024
Identifying High Gleason Score Prostate Cancer by Prostate Fluid Metabolic Fingerprint-Based Multi-Modal Recognition
Zehong Peng, Yuning Wang, Xinrui Wu, et al.
International Journal of Surgery (London, England)
|
January 5, 2024
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study
Xiaochen Fei, Xinxing Du, Jiayi Wang, et al.
The Prostate
|
December 30, 2017
Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients
Liancheng Fan, Rui Wang, Chenfei Chi, et al.
The Prostate
|
May 11, 2023
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy
Xinxing Du, Yanhao Dong, Jiazhou Liu, et al.
Communications Medicine
|
February 17, 2026
Distinct prognostic value of [<sup>18</sup>F]FDG PET and [<sup>68</sup>Ga]Ga-PSMA-11 PET in advanced hormone-sensitive prostate cancer
Ang Li, Haotian Wu, Xiang Zhou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 29, 2023
Engineering the MoS<sub>2</sub> /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens
Shaowei Xie, Xiaochen Fei, Jiayi Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 3, 2026
Intercellular Horizontal Transfer of TXNDC5 mRNA via Extracellular Vesicles Contributes to Tumor-Associated Macrophage-Mediated Prostate Cancer Metastasis
Cong Hu, Tianyang Wu, Jiayi Wang, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 142) with videos related to
Sort By:
Page
of 15
Urologic Oncology
|
April 4, 2020
Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer
Hongyang Qian, Xiaoguang Shao, Yinjie Zhu, et al.
Plos One
|
September 9, 2025
Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators
Riken Chen, Dingyu Guo, Jiahua Pan, et al.
Small Methods
|
January 23, 2024
Identifying High Gleason Score Prostate Cancer by Prostate Fluid Metabolic Fingerprint-Based Multi-Modal Recognition
Zehong Peng, Yuning Wang, Xinrui Wu, et al.
International Journal of Surgery (London, England)
|
January 5, 2024
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study
Xiaochen Fei, Xinxing Du, Jiayi Wang, et al.
The Prostate
|
December 30, 2017
Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients
Liancheng Fan, Rui Wang, Chenfei Chi, et al.
The Prostate
|
May 11, 2023
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy
Xinxing Du, Yanhao Dong, Jiazhou Liu, et al.
Communications Medicine
|
February 17, 2026
Distinct prognostic value of [<sup>18</sup>F]FDG PET and [<sup>68</sup>Ga]Ga-PSMA-11 PET in advanced hormone-sensitive prostate cancer
Ang Li, Haotian Wu, Xiang Zhou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 29, 2023
Engineering the MoS<sub>2</sub> /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens
Shaowei Xie, Xiaochen Fei, Jiayi Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 3, 2026
Intercellular Horizontal Transfer of TXNDC5 mRNA via Extracellular Vesicles Contributes to Tumor-Associated Macrophage-Mediated Prostate Cancer Metastasis
Cong Hu, Tianyang Wu, Jiayi Wang, et al.
Page
of 15